• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Psychiatry

Patients with co-occurring substance use disorder and depression less likely to receive guideline-concordant treatment

byBrian DoughertyandAlex Chan
November 3, 2020
in Psychiatry
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

RELATED REPORTS

Meditation may provide medical benefit for various health outcomes

Spiritual interventions may be associated with improved psychological and spiritual outcomes

Wellness Check: Spirituality

1. Patients with co-occurring substance use disorder and depression were less likely to received guideline-concordant treatment for depression, both in terms of pharmacology and psychotherapy, when compared with patients with depression alone.

Evidence Level Rating: 2 (Good)

It is not uncommon to find depression and substance use disorders (SUD) co-occurring, and the combination of the two leads to poorer outcomes. As such, treatment of depression is a priority for patients with SUD. However, to date there is no data examining whether patients with co-occurring SUD and depression receive similar care to those without SUD for both pharmacological- and psychotherapy-based treatment modalities. This retrospective cohort study involved veterans receiving care through the U.S. Veterans Health Administration, including 53,034 patients diagnosed with a new episode of depression, of whom 28,081 received antidepressant treatment and 18,484 received psychotherapy. In this particular cohort, 7,516 patients had a diagnosed SUD in the year prior to their diagnosis of depression. It was found that, despite having more contact with the health care system on average, patients with SUD received less guideline-concordant depression treatment across all metrics. Indeed, with regards to pharmacotherapy, acute- and continuous-phase antidepressant treatment was provided to 59.4% and 36.3%, respectively, of patients with co-occurring depression and SUD. In contrast, 66.2% and 44.8% of patients without SUD received acute- and continuous-phase antidepressant treatment. This same pattern was observed among patients receiving psychotherapy; 31.6% and 26.8% of those with SUD received acute and continuation phases of depression treatment, respectively, compared with 35.4% and 32.2% of those without SUD. Furthermore, it was found that among specific SUDs, patients with alcohol, opioid, and cannabis use disorders were more likely to receive lower-quality depression care in the acute phase. In all, this study involving a large cohort from the nation’s largest provider of health care indicates a treatment gap among those with co-occurring SUD and depression. More research needs to be done to identify strategies to deploy more equitable and effective treatment plans for patients with both SUD and depression.

Click to read the study in the American Journal of Psychiatry

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depressionpsychiatrysubstance use disorder
Previous Post

#VisualAbstract: Evolocumab successfully reduced LDL levels in pediatric patients

Next Post

Genetic susceptibility for severe Covid-19 symptoms with respiratory failure

RelatedReports

Quick Take: Intimate Partner Homicide of Adolescents
Chronic Disease

Meditation may provide medical benefit for various health outcomes

May 17, 2022
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

Spiritual interventions may be associated with improved psychological and spiritual outcomes

May 13, 2022
Wellness

Wellness Check: Spirituality

May 12, 2022
Shared decision-making tool for antidepressants improves patient and physician satisfaction
Infectious Disease

COVID-19 pandemic associated with worsening psychological distress across United Kingdom cohort studies

April 29, 2022
Next Post
SARS-CoV-2 detected on various surroundings of asymptomatic COVID-19 positive infant

Genetic susceptibility for severe Covid-19 symptoms with respiratory failure

Lirentelimab may be effective for treatment of eosinophilic gastrointestinal disease

Lirentelimab may be effective for treatment of eosinophilic gastrointestinal disease

Behavioral dysregulation in infancy predicts later child mental health

Pediatric hospitalizations decline during the COVID-19 pandemic

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir
  • Oral methylprednisolone may reduce risk of progressive renal failure in patients with IgA nephropathy: TESTING Trial
  • #VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.